Black Rock Inc. Fulcrum Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,798,522 shares of FULC stock, worth $17.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,798,522
Previous 1,541,209
211.35%
Holding current value
$17.1 Million
Previous $14.5 Million
104.48%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding FULC
# of Institutions
138Shares Held
53.9MCall Options Held
4.17MPut Options Held
515K-
Ra Capital Management, L.P. Boston, MA11.6MShares$41.3 Million1.08% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$18.7 Million2.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$11.7 Million0.0% of portfolio
-
Trv Gp Iv, LLC Boston, MA2.34MShares$8.34 Million5.16% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2MShares$7.12 Million0.01% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $185M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...